USNA vs. MNMD, ACB, CRON, BTMD, CDXC, CGC, BLFS, ARQT, CTKB, and AORT
Should you be buying USANA Health Sciences stock or one of its competitors? The main competitors of USANA Health Sciences include Mind Medicine (MindMed) (MNMD), Aurora Cannabis (ACB), Cronos Group (CRON), biote (BTMD), ChromaDex (CDXC), Canopy Growth (CGC), BioLife Solutions (BLFS), Arcutis Biotherapeutics (ARQT), Cytek Biosciences (CTKB), and Artivion (AORT). These companies are all part of the "medical" sector.
Mind Medicine (MindMed) (NASDAQ:MNMD) and USANA Health Sciences (NYSE:USNA) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, community ranking, analyst recommendations, dividends, media sentiment, institutional ownership and profitability.
USANA Health Sciences has a net margin of 6.88% compared to USANA Health Sciences' net margin of 0.00%. Mind Medicine (MindMed)'s return on equity of 12.80% beat USANA Health Sciences' return on equity.
Mind Medicine (MindMed) currently has a consensus target price of $25.20, suggesting a potential upside of 152.00%. USANA Health Sciences has a consensus target price of $48.00, suggesting a potential upside of 5.38%. Given USANA Health Sciences' stronger consensus rating and higher probable upside, equities analysts clearly believe Mind Medicine (MindMed) is more favorable than USANA Health Sciences.
27.9% of Mind Medicine (MindMed) shares are held by institutional investors. Comparatively, 54.3% of USANA Health Sciences shares are held by institutional investors. 2.1% of Mind Medicine (MindMed) shares are held by company insiders. Comparatively, 0.3% of USANA Health Sciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
In the previous week, USANA Health Sciences had 24 more articles in the media than Mind Medicine (MindMed). MarketBeat recorded 29 mentions for USANA Health Sciences and 5 mentions for Mind Medicine (MindMed). USANA Health Sciences' average media sentiment score of 0.39 beat Mind Medicine (MindMed)'s score of 0.30 indicating that Mind Medicine (MindMed) is being referred to more favorably in the media.
USANA Health Sciences has higher revenue and earnings than Mind Medicine (MindMed). Mind Medicine (MindMed) is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.
Mind Medicine (MindMed) has a beta of 2.72, indicating that its share price is 172% more volatile than the S&P 500. Comparatively, USANA Health Sciences has a beta of 0.94, indicating that its share price is 6% less volatile than the S&P 500.
USANA Health Sciences received 361 more outperform votes than Mind Medicine (MindMed) when rated by MarketBeat users. However, 89.47% of users gave Mind Medicine (MindMed) an outperform vote while only 60.77% of users gave USANA Health Sciences an outperform vote.
Summary
USANA Health Sciences beats Mind Medicine (MindMed) on 10 of the 17 factors compared between the two stocks.
Get USANA Health Sciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for USNA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding USNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
USANA Health Sciences Competitors List
Related Companies and Tools
